Your browser doesn't support javascript.
loading
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis.
Zlotoff, Daniel A; Hassan, Malek Z O; Zafar, Amna; Alvi, Raza M; Awadalla, Magid; Mahmood, Syed S; Zhang, Lili; Chen, Carol L; Ederhy, Stephane; Barac, Ana; Banerji, Dahlia; Jones-O'Connor, Maeve; Murphy, Sean P; Armanious, Merna; Forrestal, Brian J; Kirchberger, Michael C; Coelho-Filho, Otavio R; Rizvi, Muhammad A; Sahni, Gagan; Mandawat, Anant; Tocchetti, Carlo G; Hartmann, Sarah; Gilman, Hannah K; Zatarain-Nicolás, Eduardo; Mahmoudi, Michael; Gupta, Dipti; Sullivan, Ryan; Ganatra, Sarju; Yang, Eric H; Heinzerling, Lucie M; Thuny, Franck; Zubiri, Leyre; Reynolds, Kerry L; Cohen, Justine V; Lyon, Alexander R; Groarke, John; Thavendiranathan, Paaladinesh; Nohria, Anju; Fradley, Michael G; Neilan, Tomas G.
Afiliação
  • Zlotoff DA; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Hassan MZO; Cardiovascular Imaging Research Center (CIRC), Division of Cardiology and Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Zafar A; Cardiovascular Imaging Research Center (CIRC), Division of Cardiology and Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Alvi RM; Cardiovascular Imaging Research Center (CIRC), Division of Cardiology and Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Awadalla M; Cardiovascular Imaging Research Center (CIRC), Division of Cardiology and Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Mahmood SS; Cardio-Oncology Program, Cardiology Division, NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, New York, USA.
  • Zhang L; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Chen CL; Cardiology Division, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, New York, USA.
  • Ederhy S; Cardio-Oncology Program, Division of Cardiology, Hopitaux Universitaires Est Parisien, Paris, France.
  • Barac A; Cardio-Oncology Program, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC, USA.
  • Banerji D; Cardiovascular Imaging Research Center (CIRC), Division of Cardiology and Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Jones-O'Connor M; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Murphy SP; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Armanious M; Cardio-Oncology Program, Division of Cardiovascular Medicine, H. Lee Moffitt Cancer Center & Research Institute and University of South Florida, Tampa, Florida, USA.
  • Forrestal BJ; Cardio-Oncology Program, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC, USA.
  • Kirchberger MC; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Coelho-Filho OR; Discipline of Cardiology, Department of Medicine, Faculty of Medical Science, State University of Campinas, Campinas, Brazil.
  • Rizvi MA; Division of Oncology and Hematology, Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, USA.
  • Sahni G; Cardiology Division, Mount Sinai Medical Center, New York, New York, USA.
  • Mandawat A; Cardio-Oncology Program, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Tocchetti CG; Department of Translational Medical Sciences, Interdepartmental Center of Clinical and Translational Research (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Università degli Studi di Napoli Federico II, Naples, Italy.
  • Hartmann S; Cardiovascular Imaging Research Center (CIRC), Division of Cardiology and Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Gilman HK; Cardiovascular Imaging Research Center (CIRC), Division of Cardiology and Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Zatarain-Nicolás E; Cardiology Department, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red CardioVascular (CIBER-CV), Madrid, Spain.
  • Mahmoudi M; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Gupta D; Cardiology Division, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, New York, USA.
  • Sullivan R; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Ganatra S; Cardio-Oncology Program, Division of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
  • Yang EH; UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
  • Heinzerling LM; Department of Dermatology and Allergy, LMU Klinikum, Munich, Germany.
  • Thuny F; Mediterranean University Center of Cardio-Oncology, Aix-Marseille University, North Hospital, Marseille, France.
  • Zubiri L; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Reynolds KL; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Cohen JV; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lyon AR; Cardio-Oncology Service, Royal Brompton Hospital and Imperial College London, London, UK.
  • Groarke J; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Thavendiranathan P; Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Nohria A; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Fradley MG; Cardio-Oncology Program, Division of Cardiovascular Medicine, H. Lee Moffitt Cancer Center & Research Institute and University of South Florida, Tampa, Florida, USA.
  • Neilan TG; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA tneilan@mgh.harvard.edu.
J Immunother Cancer ; 9(3)2021 03.
Article em En | MEDLINE | ID: mdl-33653803

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Potenciais de Ação / Eletrocardiografia / Inibidores de Checkpoint Imunológico / Sistema de Condução Cardíaco / Frequência Cardíaca / Miocardite Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Potenciais de Ação / Eletrocardiografia / Inibidores de Checkpoint Imunológico / Sistema de Condução Cardíaco / Frequência Cardíaca / Miocardite Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido